Detection of clonally related Escherichia coli isolates producing different CMY β-lactamases from a cystic fibrosis patient

Prominence of an O75 Clonal Group (Clonal Complex 14) among Non-ST131 Fluoroquinolone-Resistant Escherichia coli Causing Extraintestinal Infections in Humans and Dogs in Australia

(2012) Joanne L. Platell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inflammatory Responses to Individual Microorganisms in the Lungs of Children With Cystic Fibrosis

(2011) C. Gangell et al.   CLINICAL INFECTIOUS DISEASES

Orthopaedic-implant infections by Escherichia coli: Molecular and phenotypic analysis of the causative strains

(2011) Lise Crémet et al.   JOURNAL OF INFECTION

Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases

(2011) Jesús Rodríguez-Baño et al.   JOURNAL OF INFECTION

CMY-42, a Novel Plasmid-Mediated CMY-2 Variant AmpC Beta-Lactamase

(2011) Moritz Hentschke et al.   Microbial Drug Resistance

The Orphan Gene ybjN Conveys Pleiotropic Effects on Multicellular Behavior and Survival of Escherichia coli

(2011) Dongping Wang et al.   PLoS One

Occurrence of ST23 Complex Phylogroup A Escherichia coli Isolates Producing Extended-Spectrum AmpC  -Lactamase in a French Hospital

(2010) L. Cremet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Changing Microbial Epidemiology in Cystic Fibrosis

(2010) J. J. LiPuma   CLINICAL MICROBIOLOGY REVIEWS

Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic β-lactamase during a 5-year period in a French teaching Hospital

(2010) Stéphane Corvec et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Extended-Spectrum Properties of CMY-30, a Val211Gly Mutant of CMY-2 Cephalosporinase

(2009) S. D. Kotsakis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Susceptibility to Cefepime among Escherichia coli Clinical Isolates Producing Novel Variants of CMY-2  -Lactamase

(2009) Y. Doi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals

(2009) P. Bogaerts et al.   PATHOLOGIE BIOLOGIE

Overproduction of Exopolysaccharides by an Escherichia coli K-12 rpoS Mutant in Response to Osmotic Stress

(2008) M. Ionescu et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

LUNG EXACERBATION IN A CYSTIC FIBROSIS (CF) PATIENT CAUSED BY A MULTIRESISTANT EXTENDED SPECTRUM β-LACTAMASE (ESBL) PRODUCING STRAIN OF ESCHERICHIA COLI (EC)

(2008) M. Caso et al.   Journal of Cystic Fibrosis